Oisix ra daichi (3182) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
6 Jun, 2025Executive summary
Sales and profits rose sharply year-over-year, driven by SHIDAX consolidation and strong BtoB and BtoC subscription business performance.
Net income surpassed the initial full-year forecast, aided by steady EBITDA and extraordinary gains from asset sales.
Operating profit rose 37.7% to ¥5,911 million, and profit attributable to owners of parent increased 17.3% to ¥3,536 million.
Comprehensive income for the period was ¥3,669 million, a 2.4% increase from the prior year.
Financial highlights
Sales: JPY 193.6bn (+116% YoY); EBITDA: JPY 10.3bn (+70.2% YoY); Operating Profit: JPY 5.9bn (+37.7% YoY); Net Income: JPY 3.5bn (+17.3% YoY).
Gross profit for the nine months was ¥57,281 million, up from ¥44,068 million year-over-year.
Earnings per share rose to ¥99.74 from ¥82.47 year-over-year.
Total assets as of December 31, 2024, were ¥139,968 million, with a shareholders' equity ratio of 21.5%.
Extraordinary income from business and investment sales contributed to net income outperformance.
Outlook and guidance
FY24 targets: JPY 255bn in sales (+72% YoY) and JPY 11bn in EBITDA (+34% YoY), both record highs.
Operating profit is projected at ¥7,000 million (+36.6%), EBITDA at ¥11,000 million (+33.5%), and profit attributable to owners of parent at ¥3,200 million (down 22.1%).
Earnings per share for the full year is forecast at ¥87.53.
BtoB profit margin expected to recover from April 2025 through price optimization.
Latest events from Oisix ra daichi
- Net income rose 23.6% YoY as B2B profit growth offset divestiture impacts.3182
Q3 202612 Feb 2026 - Sales up 4.9% YoY, net income down 61.2%, with segment realignment and divestitures ongoing.3182
Q2 202613 Nov 2025 - Strong profit growth and segment realignment, with a stable outlook despite cost pressures.3182
Q1 202613 Aug 2025 - Sales and profits soared on SHIDAX consolidation; record full-year targets set.3182
Q2 202513 Jun 2025 - Sales and EBITDA soared 116% and 57%, but net profit dropped 57% on higher costs.3182
Q1 202513 Jun 2025 - Record sales and EBITDA growth set up continued expansion and margin recovery in FY25.3182
Q4 20256 Jun 2025